Evaluation and Management of Suspected Diverticulitis in a 55-Year-Old Patient

Diagnostic Approach

Do not rely on clinical signs, symptoms, and laboratory tests alone to diagnose acute diverticulitis in this patient—imaging confirmation is essential. 1 Even with classic left lower quadrant pain, fever, and leukocytosis, clinical misdiagnosis occurs in 34–68% of cases. 2

Imaging Strategy

Obtain CT scan of the abdomen and pelvis with intravenous contrast immediately to confirm the diagnosis, distinguish uncomplicated from complicated disease, and exclude alternative diagnoses such as colorectal cancer, ischemic colitis, or inflammatory bowel disease. 1, 3 This modality has 98–99% sensitivity and 99–100% specificity for acute diverticulitis. 1, 3
If CT with IV contrast is contraindicated (severe renal disease or contrast allergy), use ultrasound as the first alternative, followed by MRI or non-contrast CT if ultrasound is inconclusive. 1
Plain abdominal radiographs have no role except to detect free air from perforation or bowel obstruction. 1, 2

Laboratory Assessment

Order complete blood count, C-reactive protein, and basic metabolic panel to assess disease severity and guide risk stratification. 4 A CRP >140 mg/L or WBC >15 × 10⁹/L indicates higher risk of progression to complicated disease. 1, 5

Classification and Risk Stratification

Uncomplicated diverticulitis is defined as localized colonic inflammation without abscess, perforation, fistula, obstruction, or bleeding—confirmed by CT imaging. 1, 3

Complicated diverticulitis involves any of these features: abscess, perforation, fistula, obstruction, or bleeding. 1, 3

High-Risk Features Predicting Progression

Identify patients at increased risk for complications or treatment failure:

Clinical: Symptom duration >5 days, vomiting, inability to maintain oral hydration, pain score ≥8/10 at presentation 1, 5
Laboratory: CRP >140 mg/L, WBC >15 × 10⁹/L or rising leukocytosis 1, 5
Imaging: Pericolic extraluminal air, fluid collection, or longer segment of colonic inflammation 1, 5
Patient factors: Age >80 years, immunocompromised status (chemotherapy, high-dose steroids, organ transplant), ASA score III–IV, significant comorbidities (cirrhosis, chronic kidney disease, heart failure, poorly controlled diabetes), pregnancy 1, 5, 3

Outpatient vs. Inpatient Management

Outpatient Eligibility (Uncomplicated Disease)

Most immunocompetent patients with uncomplicated diverticulitis can be safely managed as outpatients without routine antibiotics, achieving 35–83% cost savings per episode. 1, 5

All of the following criteria must be met:

Ability to tolerate oral fluids and medications 1, 5
No significant comorbidities or frailty 1, 5
Adequate home and social support 1, 5
Temperature <100.4°F (38°C) 1, 5
Pain controlled with acetaminophen alone (pain score <4/10) 1, 5
Immunocompetent status 1, 5
No signs of systemic inflammatory response or sepsis 1, 5

Indications for Hospitalization

Admit patients with any of the following:

Complicated diverticulitis on CT (abscess, perforation, obstruction, fistula) 1, 3
Inability to tolerate oral intake 1, 3
Severe pain or systemic symptoms (fever, sepsis) 1, 3
Immunocompromised status 1, 3
Significant comorbidities or frailty 1, 3
Any high-risk features listed above 1, 5

Antibiotic Management

Uncomplicated Diverticulitis

For immunocompetent patients with uncomplicated diverticulitis and no high-risk features, observation with supportive care alone is first-line—antibiotics are not routinely required. 1, 5, 3 Multiple high-quality randomized trials, including the DIABOLO trial (528 patients), demonstrate that antibiotics neither accelerate recovery nor prevent complications or recurrence in this population. 1, 5

Reserve antibiotics for patients with any of the following indications:

Persistent fever or chills despite supportive care 5
Refractory symptoms or vomiting 1, 5
Inability to maintain oral hydration 1, 5
Symptom duration >5 days before presentation 1, 5
CRP >140 mg/L 1, 5
WBC >15 × 10⁹/L or rising leukocytosis 1, 5
CT findings of fluid collection, abscess, extensive inflammation, or pericolic extraluminal air 1, 5
Immunocompromised status 1, 5, 3
Age >80 years 1, 5
Pregnancy 1, 5
ASA score III–IV 1, 5
Significant comorbidities (cirrhosis, chronic kidney disease, heart failure, poorly controlled diabetes) 1, 5

Antibiotic Regimens

Outpatient Oral Therapy (4–7 days for immunocompetent patients):

First-line: Amoxicillin-clavulanate 875/125 mg PO twice daily 5, 3
Alternative: Ciprofloxacin 500 mg PO twice daily PLUS metronidazole 500 mg PO three times daily 1, 5, 3

Inpatient IV Therapy (transition to oral within 48 hours when tolerated):

Ceftriaxone PLUS metronidazole 5, 3
Piperacillin-tazobactam 5, 3
Amoxicillin-clavulanate 1.2 g IV every 6 hours 5

Duration of Therapy:

Immunocompetent patients: 4–7 days total (IV → oral) 1, 5, 3
Immunocompromised patients: 10–14 days total 1, 5, 3
After percutaneous drainage of abscess: 4 days post-source control in immunocompetent patients; up to 7 days in immunocompromised or critically ill patients 1, 5

Supportive Care (All Patients)

Clear liquid diet during acute phase (2–3 days), advancing as symptoms improve 5, 3
Adequate oral hydration 5
Acetaminophen for pain control (avoid NSAIDs) 5, 3

Management of Complicated Diverticulitis

Abscess Management

Small abscess (<4–5 cm):

IV antibiotics alone for 7 days 1, 5
Hospital admission required 1, 5

Large abscess (≥4–5 cm):

Percutaneous CT-guided drainage PLUS IV antibiotics 1, 5
Obtain cultures from drainage to guide antibiotic therapy 1, 5
Continue antibiotics for 4 days after adequate source control in immunocompetent patients 1, 5

Perforation with Peritonitis

For generalized peritonitis or sepsis:

Immediate surgical consultation for emergent laparotomy 1, 5, 3
Broad-spectrum IV antibiotics (ceftriaxone plus metronidazole or piperacillin-tazobactam) 5, 3
NPO and IV fluid resuscitation 2
Surgical options include Hartmann's procedure or primary resection with anastomosis (in stable patients) 1

For CT findings of distant intraperitoneal free air without free fluid (WSES stage 2b):

Non-operative management is not recommended—surgical consultation is required 1

Laparoscopic Lavage

Do not use laparoscopic lavage as the preferred approach for elderly or high-risk patients with Hinchey III diverticulitis, as it has higher rates of inadequate source control, intra-abdominal abscess formation, and reoperation. 1

Follow-Up and Monitoring

Mandatory Re-Evaluation

All outpatients must be reassessed within 7 days of diagnosis, or sooner if clinical status worsens. 1, 5
If symptoms persist after 5–7 days of appropriate antibiotic therapy, obtain repeat CT imaging to assess for abscess formation, perforation, or other complications. 5, 2

Colonoscopy After Acute Episode

Perform colonoscopy 6–8 weeks after symptom resolution in the following patients:

First episode of uncomplicated diverticulitis (if no recent high-quality colonoscopy) 5
Any complicated diverticulitis (7.9% associated colorectal cancer risk) 5
Patients >50 years requiring routine screening 1, 5
Atypical presentation or diagnostic ambiguity 6

Do not perform colonoscopy during the acute flare-up due to increased perforation risk. 4

Prevention of Recurrence

Lifestyle Modifications

Recommend the following evidence-based measures:

High-fiber diet (≥22 g/day from fruits, vegetables, whole grains, legumes) combined with low intake of red meat and sweets 1, 5, 4
Regular vigorous physical activity 1, 5, 4
Achieve or maintain normal BMI (18–25 kg/m²) 1, 5, 4
Smoking cessation 1, 5, 4
Avoid long-term NSAIDs and opioids when possible 5, 4

Do not restrict nuts, corn, popcorn, or small-seeded fruits—these are not associated with increased diverticulitis risk. 1, 5, 4

Pharmacologic Prevention

Do not prescribe mesalamine or rifaximin for prevention of recurrent diverticulitis—high-certainty evidence shows no benefit but increased adverse events. 5

Elective Surgery Considerations

Do not base the decision for elective sigmoid resection solely on the number of prior episodes. 1, 5 Only ~20% of patients experience recurrence within 5 years, and surgery carries 10% short-term and 25% long-term complication rates. 5

Indications for Elective Resection

Consider elective sigmoid resection in the following scenarios:

Asymptomatic patients after conservatively treated episode: Generally not recommended unless high-risk features present 1
High-risk patients (if fit for surgery): Immunocompromised status (chemotherapy, organ transplant, chronic steroids) 1
Complicated disease (if fit for surgery): Stenosis, fistula, or recurrent diverticular bleeding 1
Symptomatic disease significantly impairing quality of life (if fit for surgery) 1
≥3 episodes within 2 years with persistent symptoms >3 months 5

The DIRECT trial demonstrated significantly better quality of life at 6 months and 5-year follow-up after elective surgery compared with continued conservative management in patients with recurrent/persistent symptoms. 5

Special Populations

Elderly Patients (>65 Years)

Clinical presentation is often atypical: Only 50% present with typical left lower quadrant pain, 17% have fever, and 43% lack leukocytosis. 1
Use a lower threshold for CT imaging, antibiotic treatment, and surgical consultation even when other criteria suggest outpatient management. 1, 5
Antibiotic therapy is recommended for localized complicated diverticulitis (WSES stage 1a-1b) with moderate-quality evidence. 1
In-hospital mortality is higher: 1.6% in patients <65 years, 9.7% in patients 65–79 years, and 17.8% in patients >80 years after emergency surgery. 1

Immunocompromised Patients

Immunocompromised patients require immediate antibiotic therapy (10–14 days), a lower threshold for repeat CT imaging, and early surgical consultation regardless of other factors. 1, 5, 3

Corticosteroid use specifically increases the risk of perforation and death. 5
These patients may present with milder signs and symptoms despite more severe disease. 5

Critical Pitfalls to Avoid

Do not prescribe routine antibiotics for uncomplicated diverticulitis without high-risk features—this contributes to antimicrobial resistance without clinical benefit. 1, 5
Do not assume all patients require hospitalization—most can be safely managed as outpatients with appropriate selection criteria and follow-up. 1, 5
Do not withhold antibiotics without first confirming uncomplicated disease on CT imaging—all studies supporting observation required imaging to rule out complications. 5
Do not apply the "no antibiotics" approach to complicated diverticulitis (Hinchey 1b or higher with abscess formation)—the evidence specifically excluded these patients. 5
Do not delay surgical consultation in patients with frequent recurrences significantly affecting quality of life. 5
Do not stop antibiotics early if they are indicated, even if symptoms improve—complete the full course. 5
Do not rely on a prior CT scan if symptoms persist after 5–7 days of treatment—repeat imaging is mandatory to assess for complications. 5, 2
Do not overlook elevated lactate in the setting of diverticulitis—this suggests tissue hypoperfusion from abscess, sepsis, or bowel ischemia and mandates repeat imaging. 2

Help us tailor your experience